(The following cover letter opened ICER’s published response to the comments we received on our Draft Evidence Report assessing treatments for cystic fibrosis.) Dear Stakeholders, ICER thanks each patient, caregiver, and family member who submitted public comments on our draft report on CF modulator therapies. While we are unable to respond to every letter, we […]
Neurologist Dr. Jason Crowell sits down with ICER’s President Dr. Steve Pearson to pry open the black box of US drug pricing and to wrestle with each of the financial and ethical tensions that undergird our current medical infrastructure.
This perspective, written by David Whitrap, was first shared in our Weekly View e-newsletter which summarizes the week’s most significant drug pricing news. To subscribe, click here. Season’s greetings! It’s been a tough year, and we’re all looking forward to vaccines and a return to some semblance of normalcy. But COVID-19 wasn’t the only thing that happened […]